Barbui T, Finazzi G, Falanga A (2013) Myeloproliferative neoplasms and thrombosis. Blood 122(13):2176–2184

CAS  PubMed  Google Scholar 

Falanga A, Marchetti M (2014) Thrombosis in myeloproliferative neoplasms. Semin Thromb Hemost 40(3):348–358

PubMed  Google Scholar 

Leiva O, Hobbs G, Ravid K, Libby P (2022) Cardiovascular disease in myeloproliferative neoplasms. JACC: CardioOncology 4(2):166–182

PubMed  PubMed Central  Google Scholar 

Welten GM, Schouten O, Hoeks SE, Chonchol M, Vidakovic R, van Domburg RT et al (2008) Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 51(16):1588–1596

PubMed  Google Scholar 

Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K et al (2014) Epidemiology of peripheral arterial disease and critical limb ischemia in an insured National population. J Vasc Surg 60(3):686–695 e2

PubMed  Google Scholar 

Herbreteau L, Couturaud F, Hoffmann C, Bressollette L, Pan-Petesch B, Rio L et al (2023) Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis. Thromb Res 226:93–99

CAS  PubMed  Google Scholar 

Nakagawa S, Kawarada O, Yagyu T, Matsuo J, Inoue Y, Noguchi T et al (2018) Peripheral artery disease associated with myeloproliferative disorders. JACC Cardiovasc Interv 11(16):1654–1655

PubMed  Google Scholar 

Sivakumaran Y, Freeman A (2017) Refractory arterial insufficiency associated with Janus kinase 2 positive essential thrombocythaemia. Ann Vasc Surg 38:317e13–e16

Google Scholar 

Geringer J, Fenderson J, Osswald M (2019) Essential thrombocythemia complicated by occlusive thrombosis of the abdominal aorta. Case Rep Hematol 2019:9454501

PubMed  PubMed Central  Google Scholar 

Muendlein A, Kinz E, Gasser K, Leiherer A, Rein P, Saely CH et al (2015) Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease. Am J Hematol 90(1):E17–21

CAS  PubMed  Google Scholar 

Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377(2):111–121

PubMed  PubMed Central  Google Scholar 

HCUP Nationwide Readmissions Database (NRD) Healthcare cost and utilization project (HCUP); 2014–2020

Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C et al (2018) Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet 391(10132):1775–1782

PubMed  PubMed Central  Google Scholar 

Siddiqui E, Banco D, Berger JS, Smilowitz NR (2023) Frailty assessment and perioperative major adverse cardiovascular events after noncardiac surgery. Am J Med 136(4):372–379e5

PubMed  PubMed Central  Google Scholar 

Desai RJ, Franklin JM (2019) Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ 367:l5657

PubMed  Google Scholar 

Rungjirajittranon T, Owattanapanich W, Ungprasert P, Siritanaratkul N, Ruchutrakool T (2019) A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC Cancer 19(1):184

PubMed  PubMed Central  Google Scholar 

Rollins KE, Jackson D, Coughlin PA (2013) Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischaemia. Br J Surg 100(8):1002–1008

CAS  PubMed  Google Scholar 

Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK et al (2022) Surgery or endovascular therapy for chronic Limb-Threatening ischemia. N Engl J Med 387(25):2305–2316

PubMed  Google Scholar 

Leiva O, Xia Y, Siddiqui E, Hobbs G, Bangalore S (2023) Outcomes of patients with myeloproliferative neoplasms admitted with myocardial infarction: insights from National inpatient sample. JACC CardioOncol 5(4):457–468

PubMed  PubMed Central  Google Scholar 

Leiva O, Zhou S, How J, Lee M, Hobbs G (2024) Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms. Atherosclerosis 401:119046

Pasquer H, Daltro de Oliveira R, Vasseur L, Soret-Dulphy J, Maslah N, Zhao LP et al (2024) Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38(2):326–339

PubMed  Google Scholar 

Menard MT, Farber A, Powell RJ, Rosenfield K, Conte MS, Hamza TH et al (2024) Quality of life in patients with chronic Limb-Threatening ischemia treated with revascularization. Circulation 149(16):1241–1253

CAS  PubMed  Google Scholar